Chitosan-Based Polyelectrolyte Complexes as Potential Nanoparticulate Carriers: Physicochemical and Biological Characterization

[1]  J. Turkson,et al.  Buffer-stable chitosan-polyglutamic acid hybrid nanoparticles for biomedical applications. , 2013, Macromolecular bioscience.

[2]  M. Infante,et al.  In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles. , 2013, Biomaterials.

[3]  G. De Rosa,et al.  Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells , 2013, Journal of drug delivery.

[4]  P. Taboada,et al.  Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity. , 2013, Colloids and surfaces. B, Biointerfaces.

[5]  S. Shanmugam,et al.  Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis , 2013, Drug delivery.

[6]  S. Monti,et al.  Unravelling molecular mechanisms in the fluorescence spectra of doxorubicin in aqueous solution by femtosecond fluorescence spectroscopy. , 2013, Physical chemistry chemical physics : PCCP.

[7]  Y. Huang,et al.  Salt-assisted mechanistic analysis of chitosan/tripolyphosphate micro- and nanogel formation. , 2012, Biomacromolecules.

[8]  A. Kjøniksen,et al.  Stability of chitosan nanoparticles cross-linked with tripolyphosphate. , 2012, Biomacromolecules.

[9]  D. Bikiaris,et al.  Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate. , 2012, Molecular pharmaceutics.

[10]  Wei Yan,et al.  Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. , 2012, Colloids and surfaces. B, Biointerfaces.

[11]  Kwangmeyung Kim,et al.  Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. , 2012, Biomaterials.

[12]  Kun Wang,et al.  Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. , 2011, International journal of pharmaceutics.

[13]  Kwangmeyung Kim,et al.  Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. , 2011, Biomaterials.

[14]  F. Atyabi,et al.  Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations , 2011, International journal of nanomedicine.

[15]  Andreas M. Nyström,et al.  Tuning core vs. shell dimensions to adjust the performance of nanoscopic containers for the loading and release of doxorubicin. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Krisana Siraleartmukul,et al.  Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin , 2011, Archives of pharmacal research.

[17]  S. Harding,et al.  The effect of prolonged storage at different temperatures on the particle size distribution of tripolyphosphate (TPP)-chitosan nanoparticles , 2011 .

[18]  A. Welle,et al.  Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB , 2010, Drug delivery.

[19]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[20]  R. Ramanujan,et al.  Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery , 2010 .

[21]  Amit Jain,et al.  The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes. , 2010, Biomaterials.

[22]  Miqin Zhang,et al.  Chitosan-based hydrogels for controlled, localized drug delivery. , 2010, Advanced drug delivery reviews.

[23]  Ick Chan Kwon,et al.  Targeted delivery of low molecular drugs using chitosan and its derivatives. , 2010, Advanced drug delivery reviews.

[24]  M. Loza,et al.  Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. , 2009, International journal of pharmaceutics.

[25]  A. Kabanov,et al.  Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[26]  S. Lankalapalli,et al.  Polyelectrolyte Complexes: A Review of their Applicability in Drug Delivery Technology , 2009, Indian journal of pharmaceutical sciences.

[27]  K. Kang,et al.  Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  N. M. Zaki,et al.  Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation , 2009, Pharmaceutical Research.

[29]  M. Tabrizian,et al.  Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles. , 2009, Biomaterials.

[30]  V. Ravichandiran,et al.  Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies , 2009, Lipids in Health and Disease.

[31]  Changren Zhou,et al.  Polysaccharides-based nanoparticles as drug delivery systems. , 2008, Advanced drug delivery reviews.

[32]  T. Park,et al.  Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. , 2008, Bioconjugate chemistry.

[33]  M. de la Fuente,et al.  Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. , 2008, Investigative ophthalmology & visual science.

[34]  Maryam Tabrizian,et al.  Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. , 2008, Biomaterials.

[35]  F. Wang,et al.  Designing chitosan-dextran sulfate nanoparticles using charge ratios , 2007, AAPS PharmSciTech.

[36]  Tao Wang,et al.  Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release. , 2007, Colloids and surfaces. B, Biointerfaces.

[37]  Tao Wang,et al.  Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. , 2005, Colloids and surfaces. B, Biointerfaces.

[38]  A. Domb,et al.  Chitosan chemistry and pharmaceutical perspectives. , 2004, Chemical reviews.

[39]  Tejraj M Aminabhavi,et al.  Recent advances on chitosan-based micro- and nanoparticles in drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[40]  P. Schulz,et al.  Chitosan structure in aqueous solution , 2003 .

[41]  K. Janes,et al.  Chitosan nanoparticles as delivery systems for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[42]  W. Paik,et al.  Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats. , 1995, Research communications in molecular pathology and pharmacology.

[43]  K. Chennazhi,et al.  Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications , 2011 .

[44]  A. Almond.  Visions and reflections: hyaluronan , 2007 .